Therefore, by inhibiting the expression of PTGS2 in synovial cells, the synthesis of prostaglandin E2 can be reduced, consequently reducing the inflammatory response of RA and improving the disease [52]. This evidence concerns the gene PTGS2 and rheumatoid arthritis.